AstraZeneca PLC at ASCO Virtual Scientific Program Transcript
Hi, everyone. I'm Craig Marks from the IR team. Welcome. I'll be moderating the session today. I'd like to welcome you to virtual breakout 1 on Tagrisso and immuno-oncology. Today I'm joined by Dave Fredrickson, EVP for our Oncology business unit; and Cristian Massacesi, Senior Vice President, Late Development Oncology. We have until 5 past the hour, and we'll start with a short presentation with the majority of the time allocated for Q&A. The presentation materials are available on our website as well as recording of this session.
This event is strictly for invited sell-side analysts and institutional investors. Therefore, if you are a journalist, consultant, or employee of another pharmaceutical company, please disconnect now. (Operator Instructions)
Turning to the next slide, Slide 2. You can see our safe harbor statement and forward-looking statement disclaimer that we are using today. I'm now very happy to hand over to Dave to begin the session.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |